Arrowhead Pharmaceuticals, Inc.
← Back to ARWR Overview

Arrowhead Pharmaceuticals, Inc. (ARWR)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-16.85

Financial Fundamentals

ARWR • Quarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
1998-03-31-9.75
1998-06-30—
1998-09-30-5.69
1998-12-31-6.50
1999-03-31-4.88
1999-06-300.14
1999-09-30-2.92
1999-12-31-1.38
2000-03-31-4.68
2000-06-30-3.91
2000-09-303.67
2000-12-31-1.55
2001-03-31-1.00
2001-06-30-1.62
2001-09-30-0.65
2001-12-31-0.38
2002-03-31-4.69
2002-06-30-0.31
2002-09-30-0.07
2002-12-31-0.15
2003-03-31-0.09
2003-06-30-0.38
2003-09-300.11
2003-12-31-9.03
2004-03-31-37.50
2004-06-30-37.23
2004-09-30-12.73
2004-12-31-9.64
2005-03-3124.06
2005-06-30-4.31
2005-09-30-7.79
2005-12-31-9.49
2006-03-31-13.20
2006-06-30-10.76
2006-09-30-4.84
2006-12-31-10.14
2007-03-31-6.21
2007-06-30-3.66
2007-09-30-6.38
2007-12-31-7.00
2008-03-31-4.81
2008-06-30-3.23
2008-09-30-1.29
2008-12-31-1.23
2009-03-31-1.14
2009-06-30-1.90
2009-09-30-2.82
2009-12-31-5.10
2010-03-31-9.83
2010-06-30-47.83
2010-09-30-9.37
2010-12-31-11.19
2011-03-314.69
2011-06-30-5.10
2011-09-30-3.61
2011-12-31-4.19
2012-03-31-3.19
2012-06-30-1.35
2012-09-30-1.69
2012-12-31-1.62
2013-03-31-1.30
2013-06-30-2.21
2013-09-30-3.95
2013-12-31-9.69
2014-03-31-13.24
2014-06-30-16.26
2014-09-30-8.79
2014-12-31-4.50
2015-03-31-3.32
2015-06-30-6.62
2015-09-30-3.43
2015-12-31-4.80
2016-03-31-3.44
2016-06-30-4.16
2016-09-30-5.93
2016-12-31-2.28
2017-03-31-5.71
2017-06-30-5.49
2017-09-30-7.73
2017-12-31-5.11
2018-03-31-10.01
2018-06-30-18.89
2018-09-30-40.02
2018-12-3123.88
2019-03-3118.30
2019-06-3031.54
2019-09-3058.71
2019-12-31-576.64
2020-03-31-35.96
2020-06-30-83.06
2020-09-30-22.90
2020-12-31-95.91
2021-03-31-63.76
2021-06-30-71.40
2021-09-30-25.59
2021-12-31-27.63
2022-03-3127.38
2022-06-30-13.14
2022-09-30-10.20
2022-12-31-26.00
2023-03-3113.80
2023-06-30-9.29
2023-09-30-6.59
2023-12-31-6.17
2024-03-31-6.92
2024-06-30-4.72
2024-09-30-3.46
2024-12-31-3.38
2025-03-311.15
2025-06-30-3.13
2025-09-30-50.72
2025-12-3175.44
2026-03-31-16.85

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.